On Friday, Shares of Integrated Device Technology Inc (NASDAQ:IDTI), gained 0.65% to $ 27.89.
Integrated Device Technology, declared that members of the senior administration team will present to the investment community at the following investor conferences:
- Credit Suisse Global Technology Conference
Date: Tuesday, December 1, 2015
Time: 2:00 pm MST
Location: The Phoenician, Scottsdale, AZ
- NASDAQ 33rd Investor Program
Date: Wednesday, December 2, 2015
Time: 4:15 pm GMT
Location: The May Fair Hotel, London, UK
- Wedbush Securities California Dreamin’ Administration Access Conference
Date: Wednesday, December 9, 2015
Time: 2:10 pm PST
Location: Loews Santa Monica Beach Hotel, Santa Monica, CA
Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of semiconductor solutions for the communications, computing, and consumer industries worldwide.
Shares of AEGON N.V. (ADR) (NYSE:AEG), inclined 0.82% to $6.12, during its last trading session.
Aegon Bank N.V. priced its inaugural 5-year, EUR 750 million Conditional Pass-Through Covered Bonds at 8 basis points over mid swaps resulting in an effective yield of 0.267%. The deal was oversubscribed and successfully placed with a broad range of institutional investors.
The bonds are predictable to be rated AAA by rating agencies Standard & Poor’s and Fitch. Aegon Bank N.V.’s Conditional Pass-Through Covered Bond Program is Dutch law-based and backed by a pool of prime Dutch residential mortgage loans. It is registered with the Dutch Central Bank (DNB) and is both UCITS[1]- and CRD IV[2]-compliant.
This transaction enables Aegon to further diversify its funding sources and to attract new external long-term funding. The net proceeds will be used to refinance part of the existing Dutch mortgage portfolio of Aegon.
Aegon Bank N.V. assigned ABN AMRO, Rabo bank, Royal Bank of Scotland (RBS), Société Générale and Uni Credit as joint book runners and NIBC Bank as co-lead manager for the transaction. RBS has been designated as the sole arranger.
Aegon N.V. provides life insurance, pensions, and asset administration services. The company operates through the Americas, the Netherlands, the United Kingdom, and New Markets. The company offers life and protection products, such as traditional and universal life, endowment, term, and whole life insurance products; and supplemental health, accidental death and dismemberment insurance, critical illness, cancer treatment, credit/disability, income protection, travel, and long-term care insurance.
Finally, Shares of CTI Bio Pharma Corp (NASDAQ:CTIC), ended its last trade with -3.61% loss, and closed at $1.20.
CTI BioPharma Corp., declared that administration will present at the 27th Annual Piper Jaffray Healthcare Conference on Wednesday, December 2, 2015, at 12:00 p.m. EST/6:00 p.m. CET in New York.
CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.